Oracle SOA Suite 12.2.1.4.0/14.1.2.0.0 Enterprise Scheduling System privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.4 | $0-$5k | 0.86+ |
Summary
A vulnerability was found in Oracle SOA Suite 12.2.1.4.0/14.1.2.0.0. It has been classified as critical. Impacted is an unknown function of the component Enterprise Scheduling System. Performing a manipulation results in privileges management. This vulnerability was named CVE-2026-91233. The attack may be initiated remotely. There is no available exploit. Upgrading the affected component is recommended.
Details
A vulnerability, which was classified as critical, was found in Oracle SOA Suite 12.2.1.4.0/14.1.2.0.0. This affects an unknown code block of the component Enterprise Scheduling System. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle SOA Suite product of Oracle Fusion Middleware (component: Enterprise Scheduling System). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via SOAP to compromise Oracle SOA Suite. Successful attacks of this vulnerability can result in takeover of Oracle SOA Suite. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared at oracle.com. This vulnerability is uniquely identified as CVE-2026-91233 since 09/15/2026. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 10/21/2026). MITRE ATT&CK project uses the attack technique T1068 for this issue.
Upgrading eliminates this vulnerability.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.5VulDB Meta Temp Score: 8.4
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 9.8
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
09/15/2026 CVE reserved10/21/2026 Advisory disclosed
10/21/2026 VulDB entry created
10/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-91233 (🔒)
GCVE (CVE): GCVE-0-2026-91233
GCVE (VulDB): GCVE-100-423813
Entry
Created: 10/21/2026 03:59Changes: 10/21/2026 03:59 (64)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.